These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions. Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399 [TBL] [Abstract][Full Text] [Related]
44. Acteoside protects podocyte against apoptosis through regulating AKT/GSK-3β signaling pathway in db/db mice. Li X; Liu Z; He Z; Wang X; Li R; Wang J; Ma G; Zhang P; Ma C BMC Endocr Disord; 2023 Oct; 23(1):230. PubMed ID: 37872577 [TBL] [Abstract][Full Text] [Related]
45. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice. Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH Acta Pharmacol Sin; 2017 Aug; 38(8):1129-1140. PubMed ID: 28502979 [TBL] [Abstract][Full Text] [Related]
46. Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity. He JY; Hong Q; Chen BX; Cui SY; Liu R; Cai GY; Guo J; Chen XM Acta Pharmacol Sin; 2022 Feb; 43(2):342-353. PubMed ID: 34811512 [TBL] [Abstract][Full Text] [Related]
47. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway. Wang X; Jiang L; Liu XQ; Huang YB; Wang AL; Zeng HX; Gao L; Zhu QJ; Xia LL; Wu YG Phytomedicine; 2022 Nov; 106():154400. PubMed ID: 36049428 [TBL] [Abstract][Full Text] [Related]
48. Qufeng tongluo decoction decreased proteinuria in diabetic mice by protecting podocytes via promoting autophagy. Ni B; Xiao Y; Wei R; Liu W; Zhu L; Liu Y; Ruan Z; Li J; Wang S; Zhao J; Huang W J Tradit Complement Med; 2024 May; 14(3):312-320. PubMed ID: 38707926 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y Metabolism; 2021 May; 118():154748. PubMed ID: 33675822 [TBL] [Abstract][Full Text] [Related]
50. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy. Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318 [TBL] [Abstract][Full Text] [Related]
51. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats. Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338 [TBL] [Abstract][Full Text] [Related]
52. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease. Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690 [TBL] [Abstract][Full Text] [Related]
53. A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes. Zhang J; Gu C; Lawrence DA; Cheung AK; Huang Y Exp Physiol; 2014 May; 99(5):802-15. PubMed ID: 24443353 [TBL] [Abstract][Full Text] [Related]
54. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation. Zhou G; Cheung AK; Liu X; Huang Y Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695 [TBL] [Abstract][Full Text] [Related]
55. Lycopene attenuates high glucose-mediated apoptosis in MPC5 podocytes by promoting autophagy via the PI3K/AKT signaling pathway. Wang Q; Li R; Xiao Z; Hou C Exp Ther Med; 2020 Sep; 20(3):2870-2878. PubMed ID: 32765784 [TBL] [Abstract][Full Text] [Related]
56. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Wang Y; Zhou J; Minto AW; Hack BK; Alexander JJ; Haas M; Li YC; Heilig CW; Quigg RJ Kidney Int; 2006 Sep; 70(5):882-91. PubMed ID: 16820793 [TBL] [Abstract][Full Text] [Related]
57. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318 [TBL] [Abstract][Full Text] [Related]
58. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury. Zhang J; Fu H; Xu Y; Niu Y; An X J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369 [TBL] [Abstract][Full Text] [Related]
59. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy. Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448 [TBL] [Abstract][Full Text] [Related]